Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Change in Inventory (2016 - 2025)

Corcept Therapeutics' Change in Inventory history spans 10 years, with the latest figure at -$483000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 719.23% year-over-year to -$483000.0; the TTM value through Dec 2025 reached $7.5 million, up 2552.79%, while the annual FY2025 figure was $7.5 million, 2552.79% up from the prior year.
  • Change in Inventory for Q4 2025 was -$483000.0 at Corcept Therapeutics, down from $3.9 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $4.6 million in Q2 2025 and bottomed at -$1.1 million in Q3 2024.
  • The 5-year median for Change in Inventory is -$520500.0 (2023), against an average of $63400.0.
  • The largest annual shift saw Change in Inventory plummeted 1053.49% in 2021 before it surged 464.75% in 2025.
  • A 5-year view of Change in Inventory shows it stood at -$789000.0 in 2021, then surged by 84.16% to -$125000.0 in 2022, then plummeted by 163.2% to -$329000.0 in 2023, then surged by 123.71% to $78000.0 in 2024, then crashed by 719.23% to -$483000.0 in 2025.
  • Per Business Quant, the three most recent readings for CORT's Change in Inventory are -$483000.0 (Q4 2025), $3.9 million (Q3 2025), and $4.6 million (Q2 2025).